Unternehmen GreenLight Biosciences Holdings
Aktien
GRNA
US39536G1058
GRNA
Biotechnologie
Kurzporträt
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Andrey Zarur
CEO | Chief Executive Officer | 54 | - |
Clay Mitchell
PSD | President | - | 24.07.23 |
Drew Cunningham
CTO | Chief Tech/Sci/R&D Officer | - | - |
Amin Khan
CTO | Chief Tech/Sci/R&D Officer | 61 | - |
Nina Thayer
CMP | Compliance Officer | - | 01.03.23 |
Carole Cobb
COO | Chief Operating Officer | 66 | - |
Thomas Crampton
PRN | Corporate Officer/Principal | - | - |
Mark Singleton
PRN | Corporate Officer/Principal | 56 | - |
Charu Manocha
HRO | Human Resources Officer | 57 | 01.01.20 |
Corporate Officer/Principal | 51 | - |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Andrey Zarur
CEO | Chief Executive Officer | 54 | - |
Clay Mitchell
PSD | President | - | 24.07.23 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 151 681 314 | 119 177 217 ( 78,57 %) | 0 | 78,57 % |
Unternehmenskontakt
GreenLight Biosciences Holdings PBC
29 Hartwell Avenue
02421, Lexington
+
http://www.greenlightbiosciences.comSektor
% 1. Jan. | Kap. | |
---|---|---|
+25,69 % | 47,86 Mrd. | |
+46,90 % | 41,42 Mrd. | |
-3,46 % | 40,66 Mrd. | |
-6,20 % | 28,92 Mrd. | |
+9,17 % | 25,55 Mrd. | |
-20,42 % | 19,27 Mrd. | |
+0,17 % | 12,15 Mrd. | |
+28,07 % | 12,14 Mrd. | |
-1,24 % | 11,99 Mrd. |